CO49 A Matching-Adjusted Indirect Comparison of the Efficacy of Bimekizumab and Ixekizumab at 52 Weeks for the Treatment of Radiographic Axial Spondyloarthritis
Abstract
Authors
H. Thom K. Gaffney M. Mørup V. Taieb D. Willems W.P. Maksymowych